Lutry, Switzerland

Eija Lundstrom

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovative Contributions of Eija Lundstrom in Pharmaceutical Research

Introduction

Eija Lundstrom, based in Lutry, Switzerland, is a notable inventor recognized for her significant contributions to the field of pharmaceuticals. With a focus on developing advanced drug delivery systems, she has been instrumental in creating innovative compositions that enhance the efficacy of treatments.

Latest Patents

Eija holds one patent, which is titled "Slow release pharmaceutical composition made of microgranules." This invention details a pharmaceutical composition designed to release an active substance over an extended period, specifically covering at least six months post-injection. The composition comprises microgranules made from a copolymer of the PLGA type, incorporating a water-insoluble peptide salt. Key characteristics of the microparticles include a minimum of 75% lactic acid content and a specific inherent viscosity, contributing to the precise size distribution essential for optimal drug release.

Career Highlights

Eija Lundstrom works with Debiopharm Research & Manufacturing SA, where she contributes to groundbreaking research in the pharmaceutical sector. Her work focuses on drug formulation and the development of innovative delivery systems that meet patient needs and improve therapeutic outcomes.

Collaborations

Throughout her career, Eija has collaborated with esteemed colleagues such as Bertrand Ducrey and Patrick Garrouste. These partnerships enhance her research capability, allowing for the exchange of ideas and expertise that drive innovation in pharmaceutical development.

Conclusion

Eija Lundstrom's work exemplifies the impact that dedicated inventors can have on the pharmaceutical industry. Through her patent and ongoing research endeavors, she continues to push the boundaries of drug delivery technology, benefiting patients and healthcare providers alike. Her contributions are a testament to the importance of innovation in advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…